Neuro-Oncology
神经肿瘤学
基本信息
- 批准号:8180882
- 负责人:
- 金额:$ 3.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-03 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAstatineBrain NeoplasmsCellsChildClinical TrialsCommunity Clinical Oncology ProgramDevelopmentDiagnosisDrug resistanceEpidemiologic StudiesEpidemiologyEtiologyGliomaGoalsGrantGrowthHuman poliovirusImageImmunoconjugatesImmunoglobulin FragmentsImmunotherapyInstitutesInvestigationLaboratoriesLutetiumMalignant GliomaMalignant NeoplasmsMalignant neoplasm of brainMediatingMetastatic Neoplasm to the LeptomeningesMethodsMolecularMolecular TargetMonitorMonoclonal AntibodiesOncolyticPatientsPeptidesPharmaceutical PreparationsPhasePhase III Clinical TrialsPoliovirusesPopulationPositron-Emission TomographyPrimary Brain NeoplasmsQuality of lifeRadioimmunoconjugateRadioisotopesRadiolabeledRadiometryReagentRecombinant DNARiskTargeted RadiotherapyTechnologyTherapeuticVaccinesbasechemotherapydesignimprovedinhibitor/antagonistmalignant breast neoplasmneuro-oncologyneurovirulenceprogramsradiotracerresponse
项目摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DARELL D BIGNER其他文献
DARELL D BIGNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DARELL D BIGNER', 18)}}的其他基金
Project 3: Phase-2 Trial of Oncolytic Poliovirus (PVSRIPO) combined with CCNU (lomustine) against Recurrent Glioblastoma
项目3:溶瘤脊髓灰质炎病毒(PVSRIPO)联合CCNU(洛莫司汀)治疗复发性胶质母细胞瘤二期试验
- 批准号:
10477340 - 财政年份:2018
- 资助金额:
$ 3.29万 - 项目类别:
Project 3: Phase-2 Trial of Oncolytic Poliovirus (PVSRIPO) combined with CCNU (lomustine) against Recurrent Glioblastoma
项目3:溶瘤脊髓灰质炎病毒(PVSRIPO)联合CCNU(洛莫司汀)治疗复发性胶质母细胞瘤二期试验
- 批准号:
10006179 - 财政年份:2018
- 资助金额:
$ 3.29万 - 项目类别:
Project 3: Phase-2 Trial of Oncolytic Poliovirus (PVSRIPO) combined with CCNU (lomustine) against Recurrent Glioblastoma
项目3:溶瘤脊髓灰质炎病毒(PVSRIPO)联合CCNU(洛莫司汀)治疗复发性胶质母细胞瘤二期试验
- 批准号:
10246887 - 财政年份:2018
- 资助金额:
$ 3.29万 - 项目类别:
Oncolytic Polovirus, Immunotoxin, and Checkpoint Inhibitor Therapy of Gliomas
胶质瘤的溶瘤脊髓灰质炎病毒、免疫毒素和检查点抑制剂治疗
- 批准号:
10004580 - 财政年份:2015
- 资助金额:
$ 3.29万 - 项目类别:
Oncolytic Polovirus, Immunotoxin, and Checkpoint Inhibitor Therapy of Gliomas
胶质瘤的溶瘤脊髓灰质炎病毒、免疫毒素和检查点抑制剂治疗
- 批准号:
10221622 - 财政年份:2015
- 资助金额:
$ 3.29万 - 项目类别:
Oncolytic Polovirus, Immunotoxin, and Checkpoint Inhibitor Therapy of Gliomas
胶质瘤的溶瘤脊髓灰质炎病毒、免疫毒素和检查点抑制剂治疗
- 批准号:
9751789 - 财政年份:2015
- 资助金额:
$ 3.29万 - 项目类别:
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
原发性和转移性中枢神经系统肿瘤的疫苗免疫毒素和放射免疫治疗
- 批准号:
8508884 - 财政年份:2012
- 资助金额:
$ 3.29万 - 项目类别:
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
原发性和转移性中枢神经系统肿瘤的疫苗免疫毒素和放射免疫治疗
- 批准号:
8724198 - 财政年份:2012
- 资助金额:
$ 3.29万 - 项目类别:
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
原发性和转移性中枢神经系统肿瘤的疫苗免疫毒素和放射免疫治疗
- 批准号:
8917131 - 财政年份:2012
- 资助金额:
$ 3.29万 - 项目类别:
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
原发性和转移性中枢神经系统肿瘤的疫苗免疫毒素和放射免疫治疗
- 批准号:
8216088 - 财政年份:2012
- 资助金额:
$ 3.29万 - 项目类别:
相似海外基金
CD117-Targeted Radioimmunotherapy with Astatine-211 for Acute Myeloid Leukemia and Myelodysplastic Syndrome
CD117 靶向放射免疫治疗砹 211 治疗急性髓系白血病和骨髓增生异常综合征
- 批准号:
10670383 - 财政年份:2022
- 资助金额:
$ 3.29万 - 项目类别:
Novel chemistry to improve the biostability of organo-astatine bonds in alpha-emitting radiopharmaceutical therapeutics
提高α发射放射性药物治疗中有机砹键生物稳定性的新型化学方法
- 批准号:
10286099 - 财政年份:2021
- 资助金额:
$ 3.29万 - 项目类别:
Development of Compton imaging method toward quantification of astatine-211 therapy imaging
开发康普顿成像方法以量化砹 211 治疗成像
- 批准号:
21K15855 - 财政年份:2021
- 资助金额:
$ 3.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel chemistry to improve the biostability of organo-astatine bonds in alpha-emitting radiopharmaceutical therapeutics
提高α发射放射性药物治疗中有机砹键生物稳定性的新型化学方法
- 批准号:
10430255 - 财政年份:2021
- 资助金额:
$ 3.29万 - 项目类别:
High-precision measurement of the production yield of 211-astatine by high-temperature superconducting SQUID beam ammeter
高温超导SQUID束流电流计高精度测量211-砹收率
- 批准号:
19H04403 - 财政年份:2019
- 资助金额:
$ 3.29万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of UV-vis spectroscopic system for ultratrace element astatine utilized in radionuclide therapy
放射性核素治疗用超痕量元素砹紫外-可见光谱系统的研制
- 批准号:
18K05193 - 财政年份:2018
- 资助金额:
$ 3.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of concept of liquid metal Bi targeting system for continuous production of astatine 211 for cancer treatment
用于连续生产用于癌症治疗的砹 211 的液态金属 Bi 靶向系统的概念证明
- 批准号:
18H03716 - 财政年份:2018
- 资助金额:
$ 3.29万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Evaluation of silicon-astatine exchange reaction by kinetics approach and its applications to the development of alpha-emitting therapeutic agents
动力学方法评价硅-砹交换反应及其在α发射治疗剂开发中的应用
- 批准号:
17K10459 - 财政年份:2017
- 资助金额:
$ 3.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Chemistry of radioactive radon for developing an astatine -211 generator system
用于开发砹-211发生器系统的放射性氡化学
- 批准号:
17K05807 - 财政年份:2017
- 资助金额:
$ 3.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of circulating liquid bismuth target system enabling large-scale production of astatine-211 for cancer treatment
开发循环液体铋靶标系统,可大规模生产用于癌症治疗的砹211
- 批准号:
16K13727 - 财政年份:2016
- 资助金额:
$ 3.29万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research